Drug manufacturer Moderna says it will begin testing a variant-specific version of its COVID-19 vaccine that would target the B1351 variant first detected in South Africa.
via CBC | Top Stories News
Wednesday, 24 February 2021
Moderna begins studying potential COVID-19 vaccine booster targetting variant first detected in South Africa
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment